PROSHARES TR - SHRT HGH YIELD (SJB)

Historical Holders from Q1 2014 to Q3 2025

Symbol
SJB
Type / Class
Equity / SHRT HGH YIELD
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,167,560
Holdings value
$33,325,432
% of all portfolios
0%
Number of holders
15
Number of buys
6
Number of sells
-16
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PROSHARES TR - SHRT HGH YIELD (SJB)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 2,167,560 $33,325,432 -$16,082,004 $15.38 15
2025 Q2 3,178,513 $49,989,581 +$17,166,978 $15.6 24
2025 Q1 2,063,795 $33,501,872 +$20,235,436 $16.12 18
2024 Q4 822,219 $13,278,003 -$31,197,969 $16.15 18
2024 Q3 2,741,284 $44,519,103 +$1,285,374 $16.19 31
2024 Q2 2,624,212 $44,468,228 -$14,928,998 $16.94 27
2024 Q1 3,485,717 $59,605,663 -$11,244,368 $17.1 31
2023 Q4 4,145,809 $71,404,697 -$27,168,323 $17.24 39
2023 Q3 5,759,936 $106,268,677 +$18,123,595 $18.45 39
2023 Q2 4,784,378 $87,667,770 -$53,656,639 $18.32 41
2023 Q1 7,714,949 $141,748,514 -$7,349,657 $18.36 48
2022 Q4 8,052,347 $152,999,078 +$22,645,511 $19 62
2022 Q3 6,786,325 $135,676,434 -$84,772,985 $20.01 54
2022 Q2 11,295,723 $223,152,036 +$178,532,052 $19.76 54
2022 Q1 2,219,222 $40,241,533 +$34,046,174 $18.1 31
2021 Q4 281,415 $4,911,000 -$1,627,084 $17.42 15
2021 Q3 346,793 $6,145,000 -$985,184 $17.72 14
2021 Q2 401,076 $7,192,000 -$4,490,498 $17.94 15
2021 Q1 670,089 $12,358,000 +$1,357,745 $18.45 21
2020 Q4 587,626 $10,969,000 -$8,093,692 $18.67 17
2020 Q3 1,009,134 $20,111,000 -$4,948,270 $19.93 19
2020 Q2 1,249,164 $26,117,000 -$37,365,248 $20.91 25
2020 Q1 2,647,825 $60,634,000 +$27,410,685 $22.9 27
2019 Q4 1,474,381 $30,363,000 +$442,853 $20.58 19
2019 Q3 1,436,991 $30,388,000 -$4,400,876 $21.13 19
2019 Q2 1,644,187 $35,246,125 +$6,608,167 $21.42 19
2019 Q1 1,334,462 $29,202,943 -$4,846,054 $21.88 23
2018 Q4 1,513,520 $35,626,128 -$13,115,070 $23.52 28
2018 Q3 1,796,084 $40,580,262 -$12,464,920 $22.52 20
2018 Q2 2,343,628 $54,351,595 -$20,459,820 $23.19 25
2018 Q1 3,201,751 $74,987,690 +$53,034,249 $23.38 24
2017 Q4 939,373 $21,717,560 -$6,355,781 $23.12 21
2017 Q3 1,244,753 $28,776,560 +$9,390,598 $23.12 16
2017 Q2 1,375,000 $32,355,059 -$8,397,569 $23.53 23
2017 Q1 1,696,612 $40,786,808 -$3,972,650 $24.04 19
2016 Q4 1,855,305 $45,710,000 -$45,106,224 $24.64 24
2016 Q3 3,685,936 $92,203,000 -$5,827,444 $25.01 25
2016 Q2 3,835,777 $100,621,000 +$28,777,696 $26.23 26
2016 Q1 2,715,228 $75,347,000 +$13,994,523 $27.73 25
2015 Q4 2,170,391 $62,184,000 +$5,798,416 $28.65 26
2015 Q3 1,967,200 $56,162,000 +$47,569,493 $28.56 16
2015 Q2 305,065 $8,332,000 -$714,058 $27.33 16
2015 Q1 331,731 $9,033,765 +$601,833 $27.24 14
2014 Q4 309,565 $8,666,712 -$2,050,596 $28 14
2014 Q3 382,603 $10,714,000 +$945,634 $28 13
2014 Q2 349,278 $9,635,000 -$427,411 $27.59 11
2014 Q1 363,744 $10,323,000 -$3,177,350 $28.39 14